Intracellular pharmacodynamics in leukemia therapy.
作者信息
Gandhi V, Estey E H, Keating M J, Plunkett W
机构信息
Department of Clinical Investigation, University of Texas M. D. Anderson Cancer Center, USA.
出版信息
Rinsho Ketsueki. 1996 May;37(5):369-79.
PMID:8691580
Abstract
摘要
相似文献
1
Intracellular pharmacodynamics in leukemia therapy.
Rinsho Ketsueki. 1996 May;37(5):369-79.
2
Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
Haematologica. 2000 Jul;85(7):769-70.
3
Pharmacologically directed design of leukemia therapy.白血病治疗的药理学导向设计。
Haematol Blood Transfus. 1990;33:610-3. doi: 10.1007/978-3-642-74643-7_111.
4
5
6
Modulation of arabinosylcytosine metabolism during leukemia therapy.白血病治疗期间阿糖胞苷代谢的调节
Adv Exp Med Biol. 1994;370:119-24. doi: 10.1007/978-1-4615-2584-4_27.
7
Changing the way we think about chronic lymphocytic leukemia.
J Clin Oncol. 2005 Jun 20;23(18):4009-12. doi: 10.1200/JCO.2005.08.964. Epub 2005 Mar 14.
8
[Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia].米托蒽醌联合阿糖胞苷加或不加奎宁治疗难治性或复发性急性白血病
Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S141-3.
9
Mitoxantrone.米托蒽醌
Med Lett Drugs Ther. 1988 Jul 1;30(769):67-8.
Zotero 插件